Company news

PMV Pharmaceuticals, Inc. news in 2023

PMV Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights

November 8, 2023

PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation

October 11, 2023

PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar

October 10, 2023

PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

September 19, 2023

PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights

August 8, 2023

PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights

May 9, 2023

PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights

February 28, 2023

Decks in 2023